NOAH Compendium

Printed from NOAH Compendium (https://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2025. All Rights Reserved.
Date: Saturday, June 21, 2025 21:56

Release 2.38
Poulvac Bursine 2 lyophilisate for suspension for spray vaccination or for use in drinking water for chickens (NI)
 
Species: Chickens
Therapeutic indication: Immunological veterinary medical products: For poultry
Active ingredient: Vaccine Antigens
Product:Poulvac® Bursine 2 lyophilisate for suspension for spray vaccination or for use in drinking water for chickens
Product index: Poulvac Bursine 2
Poultry - meat: Zero days
Poultry - eggs: Zero days
Incorporating:
Qualitative and quantitative composition
Each dose contains:
Active substance:
Live attenuated Infectious Bursal Disease virus, strain Lukert
≥104.3 TCID50*
*TCID50 = 50% tissue culture infective dose.
Excipients:
Qualitative composition of excipients and other constituents
Sucrose
Sodium dihydrogen phosphate dihydrate
Dipotassium phosphate
Bovine Serum Albumin
Beige to mid-brown, lyophilised.
Pharmaceutical form
Please refer to the "Qualitative and quantitative composition" section.
Clinical particulars
Target species
Chickens (broilers and future layers/breeders).
Indications for use for each target species
For the active immunisation of broilers, and future layers/breeders to reduce clinical signs caused by Infectious Bursal Disease virus.
Contraindications
None.
Special warnings
Vaccinate healthy animals only.
Maternally derived antibodies (MDA) can interfere with the development of active immunity. Where it is likely that recent field infection or vaccination of the parent flock has stimulated a high antibody titre and consequently a high level of MDA, the timing of the vaccination programme should be planned accordingly.
Very virulent Infectious Bursal Disease virus can breakthrough higher maternal antibody levels than vaccine virus.
Field infection is capable therefore of reaching birds before vaccine has a chance to take. Only use as part of a complete Infectious Bursal Disease control programme involving hygiene, biosecurity, management, stocking density and disinfection, etc. Overwhelming levels of field virus may overcome vaccinal immunity.
Special precautions for use
Special precautions for safe use in the target species:
The vaccine virus can spread to in contact birds.
Care should be taken to ensure that the vaccine virus does not spread to unvaccinated birds. It is recommended to vaccinate all chickens on a site at the same time. Cleaning and disinfection of the premises is advisable between flocks.
Special precautions to be taken by the person administering the veterinary medicinal product to animals:
If spray vaccination is applied, the user must at least protect their eyes with safety goggles and nose and mouth with a dust mask. A helmet with filtered air circulation may be used instead. It is recommended to wash and disinfect hands and equipment after vaccinating.
Special precautions for the protection of the environment:
Not applicable.
Adverse events
Chickens (broilers and future layers/breeders):
Very common
(>1 animal / 10 animals treated):
Bursal of Fabricius degeneration1, Other immune system disorder1
Very rare
(<1 animal / 10,000 animals treated, including isolated reports):
Application site reaction2,
Avian systemic disorder2
1The veterinary medicinal product produces increasing bursal damage on bird to bird passage and this is accompanied by a degree of immunosuppression.
2Reactions are usually transient.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder, or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Use during pregnancy, lactation or lay
Laying birds:
Do not use in birds in lay and within 4 weeks before the start of the laying period.
Interaction with other medicinal products and other forms of interaction
Safety and efficacy data are available which demonstrate that this vaccine can be administered on the same day but not mixed with Zoetis’s live avian infectious bronchitis virus, strain H120 in 1 day old broilers.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the products mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Administration routes and dosage
Coarse spray or in drinking water use.
Vaccination schedule:
Future layers/breeders:
Administer via drinking water.
One dose to chickens at 7 to 28 days of age. A second vaccination should be administered at 7 to 10 days after the first vaccination.
Broilers:
Administer via spray or drinking water.
One dose to chickens from 1 day of age.
Depending on the level of field virus present, repeat administration of the vaccine may be required at 7 to 10 days after the first vaccination. If not vaccinated at day old, it is recommended to determine the date of first vaccination according to the level of maternally derived antibodies (MDAs).
Nipple-drinking systems are not an appropriate method of vaccine delivery for 1-3 day old chicks.
Reconstitution of vaccine:
Upon reconstitution, light peach to a tan-brownish suspension depending on volume of water added.
Fill a container with an appropriate amount of preferably cold, fresh, non-chlorinated water that is free from metal-ions. Chlorine at levels as low as 1 ppm is known to have a detrimental effect on vaccine virus stability, therefore it’s recommended for drinking water application to add low-fat skimmed milk powder (i.e. < 1% fat, 2–4 grams per litre) or skimmed milk (20–40 ml per litre of water) to the water to prolong the life of the virus in the vaccine suspension. Only skimmed milk should be used, as the fat in whole milk may block the automatic drinking systems as well as reduce vaccine virus efficacy. After mixing, the solution should be allowed to stand for 15–30 minutes before adding the vaccine.
Remove the cap of the vaccine vial. Open the vaccine vial under water and dissolve thoroughly in the container. Empty the vaccine vial completely by rinsing the vial and the stopper in the water.
Administer to birds immediately after dilution.
Avoid exposure of the vaccine suspension to sunlight.
Drinking water:
Make sure that all conduit pipes, tubing, troughs, drinkers etc are thoroughly clean and free of any trace of disinfectants, detergents, soap, etc. Contact with disinfectants makes the vaccine ineffective.
Allow water to be consumed so that levels in drinkers are minimal before vaccine is applied. All tubing should be emptied of plain water, so that the drinkers contain only vaccine water. It may be necessary to withhold water prior to vaccination in order to ensure that all birds drink during the vaccination period. Ideally, vaccine should be administered in the volume of water consumed by the birds in up to 3 hours. The aim is to give every bird one dose of vaccine. As a general rule, apply reconstituted vaccine to chlorine-free and fresh water at the rate of 1,000 doses of the vaccine to 1 litre of water per day of age for 1,000 chickens, e.g. 10 litres would be needed for 1,000 10-day old chickens. If in doubt, measure water intake the day before administering vaccine.
Coarse Spray:
This method is for day old broiler chicks only and may be used in the hatchery or on farm.
Use clean vaccination materials only. No disinfectants or other substances impairing the performance of the live vaccine should be used in the sprayer.
Dilute and administer the reconstituted vaccine at a rate of one dose of reconstituted vaccine per bird, according to the directions of your specific coarse spray vaccination equipment. The recommended volume for 1 dose is between 0.1 and 0.5 ml. The spraying distance should be between 30 and 80 cm above the animals in order to ensure an even distribution and the recommended droplet size is greater than 100 µm.
Turn off ventilation during vaccination.
Ensure that birds are neither overheated nor chilled following coarse spray.
Symptoms of overdose (and where applicable, emergency procedures and antidotes)
No reactions other than those reported following a single dose are expected after an overdose.
Special restrictions for use and special conditions for use, including restrictions on the use of antimicrobial and antiparasitic veterinary medicinal products in order to limit the risk of development of resistance
Not applicable.
Withdrawal periods
Zero days.
Pharmacological particulars
Immunological information
ATCvet code: QI01AD09
To stimulate active immunity against Infectious Bursal Disease virus (Gumboro Disease).
The vaccine contains the live intermediate IBDV strain Lukert.
Pharmaceutical particulars
Major incompatibilities
Do not mix with any other veterinary medicinal product.
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 27 months.
Shelf life after reconstitution according to directions: 4 hours.
Special precautions for storage
Store and transport refrigerated (2 °C – 8 °C).
Protect from light.
Nature and composition of immediate packaging
Hydrolytic type I glass vial closed with type I butyl rubber stopper.
Pack sizes:
Box of 10 x 1,000 doses
Box of 10 x 2,000 doses
Box of 10 x 2,5000 doses
Box of 10 x 5,000 doses
Box of 10 x 10,000 doses
Not all pack sizes may be marketed.
Special precautions for the disposal of unused veterinary medicinal products or waste materials derived from the use of such products
Medicines should not be disposed of via wastewater or household waste.
Use take-back schemes for the disposal of any unused veterinary medicinal product or waste materials derived thereof in accordance with local requirements and with any national collection systems applicable to the veterinary medicinal product concerned.
Marketing Authorisation Holder (if different from distributor)
Zoetis Belgium S.A.
Marketing Authorisation Number
Vm 60021/3065
Significant changes
Date of the first authorisation or date of renewal
21 March 1994
Date of revision of the text
March 2025
Any other information
Classification of veterinary medicinal products
Veterinary medicinal product subject to prescription.
Detailed information on this veterinary medicinal product is available in the Union Product Database (https://medicines.health.europa.eu/veterinary).
Legal category
Legal category: POM-V
GTIN
GTIN description:10 x 1000 dose:
GTIN:08714015011785
GTIN description:10 x 5000 dose:
GTIN:08714015012386
GTIN description:10 x 10000 dose:
GTIN:08714015011808